Kevin Richard Haas Myriad Genetics Inc (MYGN) insider trading activity

Kevin Richard Haas is Chief Technology Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 132,097 shares of MYGN, which is worth approximately $3.76 Million. The most recent transaction as insider was on Mar 24, 2024, when has been sold 2,890 shares (Common Stock) at a price of $22.24 per share, resulting in proceeds of $64,273. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

0% 3M change

22.03% 12M change

Total Value Held $3.76 Million

Kevin Richard Haas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 24 2024	SELL Payment of exercise price or tax liability	$64,273 $22.24 p/Share	2,890 Reduced 2.14%	132,097 Common Stock
Mar 22 2024	SELL Payment of exercise price or tax liability	$37,474 $22.24 p/Share	1,685 Reduced 1.23%	134,987 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$69,954 $21.16 p/Share	3,306 Reduced 2.36%	136,672 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	35,178 Added 20.08%	139,978 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$20,016 $22.72 p/Share	881 Reduced 0.83%	104,800 Common Stock
Oct 09 2023	SELL Payment of exercise price or tax liability	$25,667 $15.01 p/Share	1,710 Reduced 1.59%	105,681 Common Stock
Sep 26 2023	SELL Payment of exercise price or tax liability	$13,719 $15.99 p/Share	858 Reduced 0.79%	107,391 Common Stock
Mar 24 2023	SELL Payment of exercise price or tax liability	$66,795 $23.72 p/Share	2,816 Reduced 2.54%	108,249 Common Stock
Mar 22 2023	SELL Payment of exercise price or tax liability	$38,420 $22.91 p/Share	1,677 Reduced 1.49%	111,065 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	28,459 Added 20.15%	112,742 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$18,762 $18.54 p/Share	1,012 Reduced 1.19%	84,283 Common Stock
Oct 09 2022	SELL Payment of exercise price or tax liability	$33,766 $19.62 p/Share	1,721 Reduced 1.98%	85,295 Common Stock
Sep 26 2022	SELL Payment of exercise price or tax liability	$15,869 $18.41 p/Share	862 Reduced 0.98%	87,016 Common Stock
Sep 25 2022	SELL Payment of exercise price or tax liability	$6,467 $18.69 p/Share	346 Reduced 0.39%	87,878 Common Stock
Mar 24 2022	SELL Payment of exercise price or tax liability	$71,959 $25.32 p/Share	2,842 Reduced 3.12%	88,224 Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	19,238 Added 17.44%	91,066 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$21,357 $24.69 p/Share	865 Reduced 1.19%	71,828 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	19,520 Added 21.17%	72,693 Common Stock
Oct 09 2021	SELL Payment of exercise price or tax liability	$53,392 $30.88 p/Share	1,729 Reduced 3.15%	53,173 Common Stock
Sep 26 2021	SELL Payment of exercise price or tax liability	$28,813 $33.31 p/Share	865 Reduced 1.55%	54,902 Common Stock
Sep 25 2021	SELL Payment of exercise price or tax liability	$11,525 $33.31 p/Share	346 Reduced 0.62%	55,767 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	$5,456 $15.86 p/Share	344 Added 0.61%	56,113 Common Stock
Mar 24 2021	BUY Grant, award, or other acquisition	-	13,326 Added 19.29%	55,769 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	10,000 Added 19.07%	42,443 Common Stock

KRH

Kevin Richard Haas

Chief Technology Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account